BJMO - volume 13, issue 7, november 2019
H. Van Poppel MD, PhD
The European Association of Urology (EAU) held its 34th Annual Congress in Barcelona from the 15–19th of March, a recurring highlight for the Association and for urology in general. While the presenting of the latest EAU Guidelines, holding meetings for its Board and Sections and setting agendas for the coming year are essential to the running of the Association, it is the latest scientific developments in urology that took centre stage in Barcelona.
Scientific Congress Office Chairman Prof Arnulf Stenzl (DE) presided over the scientific programme one last time, stepping down to join the EAU Executive as Adjunct Secretary General (Science). He was congratulated on his track record and particularly the comprehensive and diverse five-day programme that greeted the nearly 12,000 participants from 127 countries in Barcelona.
This article provides some uro-oncological highlights from the 263 different scientific sessions at EAU19. For the most complete coverage, see the on-site news reports on www.eau19.org/news.
(BELG J MED ONCOL 2019;13(7):314–6)
Read moreBJMO - volume 13, issue 6, october 2019
W. Lybaert MD, T. Vandamme MD, PhD, G. Boons , K. Vandenborne , L. De Backer , M. Peeters MD, PhD
MARCH 6-8TH, 2019, BARCELONA
Read moreBJMO - volume 13, issue 5, august 2019
B. Neyns MD, PhD
ASCO 2019 featured the presentation of several interesting studies in patients with metastatic melanoma. In addition to this, new data in the (neo)-adjuvant setting were presented.
Read moreBJMO - volume 13, issue 5, august 2019
T. Vermassen PhD, S. Rottey MD, PhD
From June 1st till June 5th, Chicago was host for the 55th annual ASCO meeting. This report will highlight the most important studies concerning genitourinary cancers presented during the meeting.
Read moreBJMO - volume 13, issue 5, august 2019
M.J. Piccart-Gebhart MD
At ASCO 2019, many presentations featured recent progress in the breast cancer field. A lot of attention went to biomarkers but also the treatment of triple negative breast cancer, luminal disease, HER2 positive disease as well as agnostic breast cancers subtypes were discussed.
Read moreBJMO - volume 13, issue 5, august 2019
P. Specenier MD, PhD
ASCO 2019 hosted several important presentations on Squamous Cell Carcinoma of the Head and Neck (HNSCC). Data on early stage and locally advanced HNSCC as well as recurrent/metastatic HNSCC were discussed.
Read moreBJMO - volume 13, issue 5, august 2019
J. Vansteenkiste MD, PhD, E. Wauters MD, PhD
In this article, the ten key messages with respect to thoracic oncology presented at ASCO 2019, are summarized.
Read more
Top
